Abstract
In this article, we review the use of all-cause mortality and the composite endpoint as the primary endpoint and propose a recurrent composite endpoint as an alternative primary endpoint. Some general suggestions to trialists and practitioners are provided. In summary, the use of the composite endpoint is an issue that needs clarification.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
